Vancouver, British Columbia — December 29, 2025 — Leads & Copy — PanGenomic Health Inc. (CSE: NARA) has announced a private placement offering to raise up to $2,000,000.
The offering involves up to 4,000,000 units of the company at a price of $0.50 per unit. Each unit will consist of one Class A Common share and one share purchase warrant. Each warrant can be exercised for one additional Common Share at a price of $0.75 per Warrant Share for two years from the issuance date, subject to acceleration.
The company intends to use the net proceeds for general working capital purposes and to settle outstanding indebtedness, including amounts owed to certain directors and officers.
A regulatory hold period of four months plus one day will apply to all securities issued. According to CSE policies, the offering will close no earlier than five business days from the announcement date.
Certain directors and officers of the company are expected to participate in the offering, which would be considered a “related party transaction” under Multilateral Instrument 61-101. The company expects to be exempt from formal valuation and minority shareholder approval requirements, as the Insiders’ participation is not expected to exceed 25% of the company’s market capitalization’s fair market value.
The securities are not being offered for sale in the United States and have not been registered under the U.S. Securities Act of 1933, nor will they be. These securities may not be offered or sold within the United States without registration or an applicable exemption.
PanGenomic Health is a precision health company with a self-care digital platform that delivers personalized, evidence-based information about natural treatments, initially focusing on mental health. As a British Columbia benefit company, its mission is to improve health and wellness by providing a technology platform that identifies plant-based solutions tailored to individual health profiles.
For more information, contact:
Fairfax Partners Inc.
Daniel Southan-Dwyer, President
+1 604 305 5369
fair@fairfax.partners
Source: PanGenomic Health Inc.